CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Optimi Health plans Phase III trial of PTSD therapy

Phase 3MDMA-assisted therapyPositive
AI Analysis

Summary

Optimi Health announced plans to initiate a Phase III clinical trial of MDMA-assisted therapy for PTSD treatment in Canada. No trial timeline or additional details were provided.

Clinical Trial Data

Phase

Phase III

Importance:5/10
Sentiment:
0.30
PTSDMDMA-assisted therapyclinical trialCanada
Related Companies

Read the original article

Published by Clinical Trials Arena on September 17, 2026 9:31 AM

Read Original